Significance of EpCAM and TROP2 expression in non-small cell lung cancer

World Journal of Surgical Oncology

Volumn 10, Issue , 2012, Pages

  Pak, Min G ^a   Shin, Dong H ^a,b   Lee, Chang H ^a,b   Lee, Min K ^b  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

EpCAM; Non small cell lung cancer; Prognosis; TROP2

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE; MEMBRANE PROTEIN; PROTEIN TROP2; TUMOR ANTIGEN; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; TACSTD2 PROTEIN, HUMAN; TUMOR ASSOCIATED ANTIGEN GA733; TUMOR MARKER; TUMOR-ASSOCIATED ANTIGEN GA733;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; DISEASE FREE SURVIVAL; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; ONCOGENE; OVERALL SURVIVAL; SCORING SYSTEM; TACSTD GENE; ADENOCARCINOMA; BIOSYNTHESIS; CHI SQUARE DISTRIBUTION; GENE EXPRESSION; HEALTH SURVEY; KAPLAN MEIER METHOD; LUNG TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SIGNAL TRANSDUCTION; SOUTH KOREA; SQUAMOUS CELL CARCINOMA; STATISTICS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; CHI-SQUARE DISTRIBUTION; FEMALE; GENE EXPRESSION; HEALTH STATUS INDICATORS; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; REPUBLIC OF KOREA; SIGNAL TRANSDUCTION; STATISTICS AS TOPIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84859402736     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-10-53     Document Type: Article

References (17)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
2. Piyathilake CJ, Frost AR, Weiss H, Manne U, Heimburger DC, Grizzle WE. The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung. Hum Pathol 2000, 31:482-487. 10.1053/hp.2000.6711, 10821496.
3. Keedy VL, Temin S, Somerfield MR, Beasley MB, Johnson DH, McShane LM, Milton DT, Strawn JR, Wakelee HA, Giaccone G. American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy. J Clin Oncol 2011, 29:2121-2127. 10.1200/JCO.2010.31.8923, 21482992.
4. Wenqi D, Li W, Shanshan C, Bei C, Yafei Z, Feihu B, Jie L, Daiming F. EpCAM is overexpressed in gastric cancer and its downregulation suppresses proliferation of gastric cancer. J Cancer Res Clin Oncol 2009, 135:1277-1285. 10.1007/s00432-009-0569-5, 19294417.
5. Cubas R, Li M, Chen C, Yao Q. Trop2: a possible therapeutic target for late stage epithelial carcinomas. Biochim Biophys Acta 2009, 1796:309-314.
6. Went PT, Lugli A, Meier S, Bundi M, Mirlacher M, Sauter G, Dirnhofer S. Frequent EpCam protein expression in human carcinomas. Hum Pathol 2004, 35:122-128. 10.1016/j.humpath.2003.08.026, 14745734.
7. Baeuerle PA, Gires O. EpCAM (CD326) finding its role in cancer. Br J Cancer 2007, 96:417-423. 10.1038/sj.bjc.6603494, 2360029, 17211480.
8. Went P, Dirnhofer S, Salvisberg T, Amin MB, Lim SD, Diener PA, Moch H. Expression of epithelial cell adhesion molecule (EpCam) in renal epithelial tumors. Am J Surg Pathol 2005, 29:83-88. 10.1097/01.pas.0000.146028.70868.7a, 15613858.
9. Spizzo G, Went P, Dirnhofer S, Obrist P, Simon R, Spichtin H, Maurer R, Metzger U, von Castelberg B, Bart R, Stopatschinskaya S, Kochli OR, Haas P, Mross F, Zuber M, Dietrich H, Bischoff S, Mirlacher M, Sauter G, Gastl G. High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer. Breast Cancer Res Treat 2004, 86:207-213. 10.1023/B:BREA.0000036787.59816.01, 15567937.
10. Ohmachi T, Tanaka F, Mimori K, Inoue H, Yanaga K, Mori M. Clinical significance of TROP2 expression in colorectal cancer. Clin Cancer Res 2006, 12:3057-3063. 10.1158/1078-0432.CCR-05-1961, 16707602.
11. Fong D, Spizzo G, Gostner JM, Gastl G, Moser P, Krammel C, Gerhard S, Rasse M, Laimer K. TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity. Mod Pathol 2008, 21:186-191.
12. Nishio M, Koshikawa T, Yatabe Y, Kuroishi T, Suyama M, Nagatake M, Sugiura T, Ariyoshi Y, Mitsudomi T, Takahashi T. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers. Clin Cancer Res 1997, 3:1051-1058.
13. Kobayashi H, Minami Y, Anami Y, Kondou Y, Iijima T, Kano J, Morishita Y, Tsuta K, Hayashi S, Noguchi M. Expression of the GA733 gene family and its relationship to prognosis in pulmonary adenocarcinoma. Virchows Arch 2010, 457:69-76. 10.1007/s00428-010-0930-8, 20473768.
14. Cubas R, Zhang S, Li M, Chen C, Yao Q. Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway. Mol Cancer 2010, 9:253-265. 10.1186/1476-4598-9-253, 2946292, 20858281.
15. El Sewedy T, Fornaro M, Alberti S. Cloning of the murine TROP2 gene: conservation of a PIP2-binding sequence in the cytoplasmic domain of TROP-2. Int J Cancer 1998, 75:324-330. 10.1002/(SICI)1097-0215(19980119)75:2<324::AID-IJC24>3.0.CO;2-B, 9462726.
16. Fornaro M, Dell'Arciprete R, Stella M, Bucci C, Nutini M, Capri MG, Alberti S. Cloning of the gene encoding Trop-2, a cell-surface glycoprotein expressed by human carcinomas. Int J Cancer 1995, 62:610-618. 10.1002/ijc.2910620520, 7665234.
17. Nakatsukasa M, Kawasaki S, Yamasaki K, Fukuoka H, Matsuda A, Tsujikawa M, Tanioka H, Nagata-Takaoka M, Hamuro J, Kinoshita S. Tumor-associated calcium signal transducer 2 is required for the proper subcellular localization of claudin 1 and 7: implications in the pathogenesis of gelatinous drop-like corneal dystrophy. Am J Pathol 2010, 177:1344-1355. 10.2353/ajpath.2010.100149, 2928967, 20651236.